FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 80 filers reported holding FORTRESS BIOTECH INC in Q1 2022. The put-call ratio across all filers is 1.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,061 | -23.4% | 38,100 | +45.2% | 0.00% | – |
| Q2 2023 | $14,432 | -14.3% | 26,241 | +27.8% | 0.00% | – |
| Q1 2023 | $16,840 | -92.2% | 20,537 | -92.0% | 0.00% | – |
| Q2 2022 | $215,000 | -35.4% | 256,169 | +4.4% | 0.00% | – |
| Q1 2022 | $333,000 | -21.3% | 245,443 | +45.0% | 0.00% | – |
| Q4 2021 | $423,000 | -26.4% | 169,263 | -5.2% | 0.00% | – |
| Q3 2021 | $575,000 | -24.7% | 178,511 | -16.6% | 0.00% | – |
| Q2 2021 | $764,000 | +3720.0% | 213,930 | +1488.9% | 0.00% | – |
| Q2 2019 | $20,000 | +81.8% | 13,464 | +4.4% | 0.00% | – |
| Q4 2018 | $11,000 | -77.1% | 12,898 | -57.0% | 0.00% | – |
| Q3 2018 | $48,000 | -61.9% | 30,028 | +8.1% | 0.00% | – |
| Q1 2018 | $126,000 | +24.8% | 27,779 | +21.9% | 0.00% | – |
| Q3 2017 | $101,000 | +165.8% | 22,793 | +61.4% | 0.00% | – |
| Q2 2016 | $38,000 | -40.6% | 14,124 | -31.6% | 0.00% | – |
| Q1 2016 | $64,000 | +146.2% | 20,635 | +108.1% | 0.00% | – |
| Q3 2015 | $26,000 | – | 9,918 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,000,000 | $580,600 | 0.19% |
| Nantahala Capital Management | 6,018,211 | $1,747,087 | 0.15% |
| THOMPSON DAVIS & CO., INC. | 12,996 | $3,773 | 0.01% |
| Platform Technology Partners | 30,000 | $8,709 | 0.00% |
| Black Maple Capital Management LP | 15,000 | $4,355 | 0.00% |
| Arete Wealth Advisors, LLC | 52,547 | $15,254 | 0.00% |
| B. Riley Wealth Advisors, Inc. | 144,700 | $42,006 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 1,075,531 | $311 | 0.00% |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 1,542,000 | $447,643 | 0.00% |
| GROUP ONE TRADING, L.P. | 2,000 | $581 | 0.00% |